CA Patent

CA2913692A1 — Quantification of absolute blood flow in tissue using fluorescence mediated photoplethysmography

Assigned to Novadaq Technologies ULC · Expires 2015-01-08 · 11y expired

What this patent protects

There is provided a method an d a system for quantification of absolute blood flow in tissue using near-infrared fluorescence angiography in conjunction with photoplethysmography (fluorescence-mediated photoplethysmography). The method and system of the present invention provide …

USPTO Abstract

There is provided a method an d a system for quantification of absolute blood flow in tissue using near-infrared fluorescence angiography in conjunction with photoplethysmography (fluorescence-mediated photoplethysmography). The method and system of the present invention provide absolute, real-time measurements of flow in terms of volume/time/area based upon measurement of fluorescence intensity.

Drugs covered by this patent

Patent Metadata

Patent number
CA2913692A1
Jurisdiction
CA
Classification
Expires
2015-01-08
Drug substance claim
No
Drug product claim
No
Assignee
Novadaq Technologies ULC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.